After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been awarded a total of $7,268,202 from the Kuni Foundation’s Discovery Grant ...

Vaccine and Infectious Disease Division scientists pursue vaccines and therapies for infectious disease such as HIV through integrated and collaborative research and clinical care.

Be part of an amazing community that comes together to support one another, raise awareness and fund research to help stop multiple myeloma. Defeat Myeloma has donated more than $1.4 million dollars ...

The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), located at Fred Hutch Cancer Center, is a statistical and data management center (SDMC) dedicated to supporting investigators who ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing hematopoietic cell transplantation (HCT) and other cancer treatments.

See the latest reports from the Hutchinson Institute for Cancer Outcomes Research (HICOR).

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.